Please login to the form below

Not currently logged in
Email:
Password:

addiction

This page shows the latest addiction news and features for those working in and with pharma, biotech and healthcare.

Alkermes slumps as FDA turns down depression drug

Alkermes slumps as FDA turns down depression drug

treat addiction, and samidorphan, a new mu-opioid receptor antagonist.

Latest news

More from news
Approximately 3 fully matching, plus 53 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Hanover appoints new associate director Hanover appoints new associate director

    Previously he spent five years in-house with Schering-Plough and MSD, working on brand communications across immunology, CVD, respiratory, virology and addiction portfolios.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics